Among the pleiotropic effects of Nef proteins of HIV and simian immunodeficiency virus (SIV), down-modulation of cell surface expression of CD4 is a prominent phenotype. It has been presumed that Nef proteins accelerate endocytosis of CD4 by linking the receptor to the AP-2 clathrin adaptor. However, the related AP-1 and AP-3 adaptors have also been shown to interact with Nef, hinting at role(s) for these complexes in the intracellular retention of CD4. By using genetic inhibitors of endocytosis and small interfering RNA-induced knockdown of AP-2, we show that accelerated CD4 endocytosis is not a dominant mechanism of HIV-1 (NL4-3 strain) Nef in epithelial cells, T lymphocyte cell lines, or peripheral blood lymphocytes. Furthermore, we show that both the CD4 recycling from the plasma membrane and the nascent CD4 in transit to the plasma membrane are susceptible to intracellular retention in HIV-1 Nefexpressing cells. In contrast, AP-2-mediated enhanced endocytosis constitutes the predominant mechanism for SIV (MAC-239 strain) Nef-induced down-regulation of human CD4 in human cells.
The cytoplasmic domains of plasma membrane receptors contain sequence determinants that regulate orderly protein sorting during anterograde transport, specify organelle targeting, and determine the intracellular fate of internalized receptors after agonist binding or cell activation (1) (2) (3) . Animal viruses have evolved several strategies to subvert mechanisms of protein sorting, resulting in aberrant trafficking, intracellular trapping, and degradation of targeted receptors.
Among the viral modulators of receptor expression and trafficking, the 27-32 kDa myristoylated Nef proteins of HIV 1 and SIV have been most extensively characterized for their ability to down-regulate CD4 and HLA-I receptors (reviewed in Refs. 4 -6) . These receptors are modulated by different mechanisms and require distinct subdomains of Nef (7) (8) (9) (10) (11) . Nef reduces the steady-state levels of CD4 apparently by accelerating receptor endocytosis and misdirecting the internalized CD4 to lysosomes for breakdown. A membrane-proximal dileucine motif in the cytoplasmic tail of CD4 is both necessary and sufficient for the HIV-1 Nef-mediated down-regulation (12, 13) . Specific interactions of Nef with the components of heterotetrameric adaptor complexes are critical determinants of this process.
Mutations at the 2 leucines in the highly conserved (D/ E)XXXL(L/I) dileucine motif in the solvent-exposed, C-terminal flexible loop of both HIV and SIV Nef proteins abolish AP-1 and AP-3 adaptor binding and CD4 down-regulation (10, 11, 14, 15) . Furthermore, CD4-Nef or CD8-Nef chimeras fusing the ecto-and transmembrane domains of CD4 or CD8 to Nef undergo rapid endocytosis in a dileucine motif-dependent manner (11, 16) . SIV Nef has an additional tyrosine-based sorting signal of the type YXXØ, which presumably binds to the AP-2 complex and is implicated in enhancing endocytosis of CD4 (17, 18) . From these findings, Nef is presumed to serve as a "connector" between CD4 and the endocytic machinery (6, 16) . Such a role would necessitate a physical interaction between Nef and CD4. CD4-Nef complexes have been demonstrated in insect cells overexpressing both proteins (19) , in a yeast two-hybrid system (20) , and in in vitro binding assays with Nef protein and peptides corresponding to the CD4 cytoplasmic domain (21, 22) . The objectives of this study were to inquire whether endocytic enhancement is the sole mechanism of Nef-induced CD4 down-modulation and to elucidate the differences, if any, in the mechanisms of HIV-1 and SIV Nef with respect to recruitment of different adaptor complexes and subunits in the process. Using a yeast three-hybrid assay, we demonstrated recently that (D/E)XXXL(L/I)-type signals from HIV and SIV Nefs interacted in a bipartite manner with the adaptor hemicomplexes, ␥⅐1 of AP-1 and ␦⅐3 of AP-3. The analogous ␣⅐2 of AP-2 and ⑀⅐4 subunits of AP-4 did not interact with Nef. Interaction of HIV-1 Nef protein with the individual subunits of AP complexes was much weaker or non-existent (15) .
We have extended the above studies to show that the loss of CD4 at the cell surface of HIV-1 Nef-expressing cells did not result exclusively from accelerated endocytosis of CD4. Both the recycling CD4 and the nascent receptor in transit to the plasma membrane were susceptible to intracellular retention and degradation in HIV-1 Nef-expressing cells. In contrast, SIV Nef-induced CD4 down-regulation resulted mostly from enhanced endocytosis and was dramatically reversed by genetic inhibitors of endocytosis or small interfering RNA (siRNA)-driven knockdown of AP-2 complexes.
EXPERIMENTAL PROCEDURES
Cells and Viruses-Human T cell lines used in this study included CD4-positive Jurkat cells or the A3.01 derivative of CEM cells and CD4-negative A2.01 cells. These T cell lines and a HeLa CD4 cell line, clone 6C (HT-6C), were obtained from the National Institutes of Health AIDS Research and Reference Reagent Program, Rockville, MD and propagated. The T lymphocytes were propagated in RPMI with 10% fetal calf serum (FCS) and the HeLa CD4 cell line in Dulbecco's modified Eagle's medium (DMEM) with 10% FCS. The HeLa CD4 cells were monitored periodically for the inevitable outgrowth of CD4(Ϫ) cells, at which time they were selected on G418 (500 g/ml) for two passages. Human T cell lines expressing wild type CD4 (line A2D8), or the tCD4 mutant (line T402), truncated at the 402nd residue and thus lacking the C-terminal domain, were constructed by retroviral transduction of the CD4-negative T cell line A2.01 using a retroviral vector and neomycin selection (23) and maintained in RPMI medium supplemented with 10% fetal bovine serum and periodically selected by G418 (500 g/ml) as above. PBLs were isolated from whole blood, buffy coat, or lymphocyterich leukopaks provided by the Department of Transfusion Medicine at the National Institutes of Health. Red blood cells were disrupted with ammonium chloride in potassium bicarbonate lysis solution and removed by gentle centrifugation. The final pellet of d0 peripheral blood mononuclear cells was suspended in RPMI with 10% FCS. For T-cell activation, peripheral blood mononuclear cells purified by banding after Ficoll-Hypaque centrifugation were stimulated by CD3 mAb for 36 h in the presence of interleukin-2 (20 IU/ml) in RPMI with 10% FCS, following which they were propagated in medium containing interleukin-2 (24) .
All the recombinant vaccinia viruses used in this work had been constructed by homologous recombination at the thymidine kinase locus of the vaccinia virus genome. Plasmid pSC11 was used as the transfer vector. pSC11 contains the vaccinia virus 7.5K promoter for the expression of foreign genes and also had an Escherichia coli lac-Z gene linked to the vaccinia virus 11k promoter. The following recombinant vaccinia viruses were used: 1) for negative control, the recombinant vaccinia virus (vSC8) encoding the E. coli lac-Z (25); 2) vvNef that was isogenic with vSC8 except for the Nef gene linked to the 7.5K promoter (26); 3) vvCD4 (vCB-7) expressing WT full-length human CD4 (27); 4) vvtCD4 (vCB-2) expressing CD4 truncated at residue 402 (and modified by the addition at the C terminus of a Leu-Ileu-Asn sequence during DNA cloning) and thus lacking the cytoplasmic domain (28); 5) vvgp160 (vPE16) expressing the HIV-1 envelope glycoprotein, gp160 (29, 30) ; and 6) vvCD46, expressing the human CD46 protein (31) . Cloned virus stocks were plaque-purified thrice on CV-1 cells, propagated in HeLa S3 suspension cells, and purified by banding on sucrose gradients by ultracentrifugation (29, 30) . For expression studies, cells were infected at a multiplicity of infection of 5 or 10 plaque-forming units/cell unless indicated otherwise.
Recombinant DNA Constructs-The original Nef expression plasmid, pCMV-Nef, has been described (32) . For expression in mammalian cells, wild type or mutant Nef cDNAs were PCR-amplified from the respective HIV and SIV proviruses or other recombinant plasmids and cloned into EcoRI-SalI sites of pCI-neo vector (Promega, Madison, WI). CMV promoter-linked CD4 and CD8 plasmids were obtained from the National Institutes of Health AIDS Research and Reference Reagent Program, Rockville MD. CD4 was mutated by a two-step PCR mutagenesis protocol (33) to exchange the codons for 2 leucines at 438 -439 to alanines and cloned into the pCI-neo vector to generate LL/AA CD4. Dominantnegative Eps15 deletion mutant fused N-terminally to GFP (GFPEps15⌬95/295) was obtained from Alexandre Benmerah at INSERM, Paris, France (34) . GFP-tagged WT dynamin and the K44A dominantnegative dynamin mutant (35) were from Julie Donaldson at NICHD, National Institutes of Health, Bethesda, MD. EYFP-tagged Rab5 and Rab5-S34N have been described (24) .
Antibodies-The following mouse monoclonal antibodies were obtained: 1) against ␣, ␥, ␦, and ⑀-adaptins, unconjugated or dye-conjugated CD71 (transferrin receptor, TfnR), and unconjugated CD46 (BD Transduction and Pharmingen Laboratories) and 2) unconjugated, Alexa Fluor 488-, PE-, or APC-conjugated CD4 and CD8 mAbs (Caltag Laboratories, Burlingame, CA). The following polyclonal antibodies were also used: 1) against the 3 subunit of AP-3 adaptor (36) and 2) against TfnR (Zymed Laboratories Inc., South San Francisco, CA). Monoclonal antibody (TW 2.3) against the vaccinia virus E3L gene product (37) was a gift from Jonathan Yewdell, NIAID, National Institutes of Health. Rabbit antiserum against HIV-1 gp160 protein was a gift of Ronald Willey, NIAID, National Institutes of Health. Secondary antibodies to mouse, rabbit, goat, and sheep IgG conjugated to Alexa Fluor 488, 568, or 647 dyes were from Molecular Probes Inc. (Eugene, OR).
Cell Culture and Transfections-HeLa cells, cultured in DMEM supplemented with 10% FCS (v/v), were transfected using the Lipofectamine Plus reagent (Invitrogen) according to the manufacturer's instructions. PBLs were isolated from whole blood, buffy coat, or lymphocyte-rich leukopaks provided by the Department of Transfusion Medicine at the Clinical Center, National Institutes of Health, as described (24) . CD4ϩ T cells were enriched by negative selection using magnetic bead technology (Miltenyi Biotec Inc., Auburn, CA). PBLs and T cell lines were transfected using an Amaxa Biosystems electroporator with the recommended reagents (AMAXA Inc., Gaithersburg, MD).
Flow Cytometry-General protocols of flow cytometry using HeLa cell transfectants, primary T cells, and lines have been described before (24) . In all transfections, plasmids encoding EGFP or CD8 were included to normalize for transfection efficiency. For detection of internal antigens, the cells were permeabilized with 0.1% saponin treatment and fixed in 4% paraformaldehyde prior to antibody staining in the presence of 0.1% saponin. Vaccinia virus infection was monitored by FACS analysis of cells permeabilized by saponin, using a monoclonal antibody (TW 2.3) against the vaccinia virus E3L gene product (37) . At 4 h after vaccinia virus infection, 40 -60% of cells scored positively with this antibody.
CD4 Endocytosis and Recycling-CD4 endocytic kinetics was determined by flow cytometry assay essentially as described previously (38, 39) . HeLa cells were co-transfected with WT or mutated CD4 along with WT Nef or the NefXho (NX) Nef deletion mutant. Alternatively, Jurkat cells were transfected with Nef or NX plasmid. In all transfections, CD8 plasmid was included to enable gating of transfected cells. At 30 h after transfection, cells were reacted with PE-conjugated Leu3A mAb for 30 min on ice in DMEM or RPMI 1640 (for Jurkat cells) containing 0.5% bovine serum albumin. An aliquot of cells was co-stained at 0 -4°C with CD8 APC to determine the transfection efficiency and CD4 PE to quantify the CD4 receptor density at the cell surface. The bulk of the cells that had been stained with CD4 PE only were rinsed thrice with RPMI containing 0.5% bovine serum albumin at 2-4°C to remove the excess unbound antibody and incubated at 37°C. At the indicated times, dual 50-l aliquots were diluted with 5-10 volumes of RPMI at neutral or acid pH (pH 2 for HeLa cells, pH 3 for Jurkat cells) and incubated for 45 s at 2-4°C. After rinsing with neutral pH RPMI, cells were fixed in 4% paraformaldehyde in PBS for 10 min at 2-4°C, rinsed with PBS, and counterstained with CD8-APC and processed for flow cytometry. Mean 
For microscopic visualization of CD4 endocytosis, fluorescent antibody was fed to living cells together with fluorescent transferrin as a monitor for clathrin-dependent endocytosis of TfnR. HeLa cells transiently expressing CD4, WT Nef, or Nef-Xho mutant and GFP-or YFP-tagged dominant-negative inhibitors of endocytosis were used. Cells on coverslips at 50% confluence were starved for 30 min at 37°C in DMEM without serum. They were then incubated at 37°C for 30 min in 200 l of DMEM (with 0.5% bovine serum albumin) with Alexa Fluor 568-conjugated Tfn (50 g/ml) and APC-labeled CD4 mAb (10 l of mAbs or 1-2 g of equivalent). Cells were rinsed thrice with PBS, fixed with paraformaldehyde, rinsed and mounted in Fluoromount-G (Southern Biotechnology Associates, Birmingham, AL). In some experiments (indicated in the relevant figure legends), cell surface bound antibody was stripped by treatment for 1-2 min with 0.5% acetic acid in 500 mM NaCl after the first rinse before fixation.
CD4 recycling was calculated as described (39) with slight modifications. HeLa cell transfectants were labeled with PE-conjugated CD4 mAb as for endocytosis studies, incubated at 37°C for 30 min to maximize antibody internalization, rinsed, and suspended in 5 volumes of RPMI at pH 2 at 4°C for 2 min. Cells were then transferred to neutral buffer, and a time 0 aliquot was collected, fixed, and counterstained with CD8-APC and analyzed by FACS. The remaining cells were warmed to 37°C for the indicated times, placed in timed aliquots, washed in cold acid, fixed, and counterstained for CD8. CD4 MFVs in the CD8 gated population was determined by FACS analysis. The percentage of recycled CD4 was determined by dividing the MFVs during the rewarming period by the acid-resistant MFV before rewarming.
Yeast Culture, Transformation, and Two-and Three-hybrid AssaysTwo-hybrid genetic analysis between various Nefs and the adaptor subunits was carried out as described before (15) . The Saccharomyces cerevisiae strain HF7c (Clontech) was maintained on dropout agar plates lacking methionine. Transformation was performed by the lithium acetate procedure as described in the instructions for the MATCH-MAKER two-hybrid kit (Clontech). HF7c transformants were selected by spreading on plates lacking leucine, tryptophan, and methionine. For colony growth essays, HF7c transformants were dotted on plates lacking leucine, tryptophan, methionine, and histidine complemented with 3 mM 3-aminotriazole (Sigma) and allowed to grow at 30°C for 3-5 days.
Metabolic Labeling and Immunoprecipitation-For metabolic labeling experiments, transfected or virus-infected HeLa cells or T cells (10 6 - 10 7 ) were rinsed thrice with PBS and incubated in methionine and cysteine-free DMEM containing 1% dialyzed FCS (0.2 ml/sample) for 10 min. For steady-state labeling, cells were incubated for 1 h by the addition of 35 S-labeled Trans-label (ICN Corp) to 1 mCi/ml. For measuring the kinetics of protein biosynthesis, 2 ϫ 10 7 cells were labeled for 15 min in 500 l of labeling medium (1 mCi/ml). At the end of the labeling, the cells were diluted with 10 volumes of complete RPMI medium. Aliquots were removed immediately after labeling and at the indicated periods during the chase (from 0 to 12 h). The cells were rinsed twice in PBS and processed for SDS-PAGE analysis. The cells were disrupted by three cycles of freeze-thawing (thawing to 37°C for 1-2 min to disrupt rafts) in 500 l of extraction buffer containing 0.05 M Tris-HCl, pH 7.4, 100 mM NaCl, 0.25% Nonidet P-40 (or CHAPS), 0.25% Triton X-100, and one tablet of protease inhibitor mix (Roche Applied Science) followed by extraction at 4°C for 1 h. The extracts were centrifuged at 10,000 ϫ g for 10 min, and supernatants were used for immunoprecipitation. The supernatants were precleared by incubation for 1 h at 4°C with 30 l of immobilized protein G agarose beads (Pierce) coated with preimmune rabbit or mouse sera. Labeled proteins were immunoprecipitated for 3 h at 4°C with protein G agarose beads prebound to the corresponding anti-rabbit polyclonal or anti-mouse monoclonal antibodies. Following specific antibody binding, the beads were collected by centrifugation and washed five times with 10 -20 volumes of extraction buffer lacking protease inhibitors, and the labeled proteins were eluted by boiling in 50 l of a buffer containing Tris-HCl, pH 7.4, 100 mM NaCl, 50 mM dithiothreitol, 2% SDS, glycerol (10% v/v), and bromphenol blue (0.1% w/v). The radiolabeled proteins were resolved by SDS-PAGE and visualized by phosphorimaging and quantified.
Immunofluorescence Microscopy-Twenty-four hours after transfection, HeLa cells grown on glass coverslips were stained for immunofluorescence microscopy. Cells were fixed in 4% paraformaldehyde in PBS and permeabilized for 10 min with 0.1% (w/v) Triton X-100 in PBS. After permeabilization, the cells were blocked for 30 min with 1% normal goat serum in PBS and incubated for 30 min at room temperature with the primary antibody, washed with PBS, and then incubated for 30 min with the secondary antibody. The different combinations of 1°and 2°antibodies and GFP or GFP fusion proteins are indicated in the respective figure legends. The coverslips were washed and mounted on slides. Images were collected on a Leica TCS-NT/SP confocal microscope (Leica Microsystems, Exton, PA) using a ϫ63 or ϫ100 oil immersion objective NA 1.32 and digital zoom up to ϫ5. Fluorochromes were excited using an argon laser at 488 nm for Alexa Fluor 488 or fluorescein isothiocyanate, a krypton laser at 568 nm for Alexa Fluor 568 or Texas Red, and a helium/neon laser at 633 nm for APC. Fluorescent emission from Alexa Fluor 350 dye was visualized by excitation with a UV laser. Detector slits were configured to minimize any cross-talk between the channels, or the channels were collected separately and later superimposed. Differential interference contrast images were collected simultaneously with the fluorescence images using the transmitted light detector. Eight or more fields were examined per coverslip, and each experimental condition was repeated as indicated in the respective figure legends.
RNA-mediated Interference-RNA-mediated interference of 2 adaptor subunit or vps35 was performed using an siRNA duplex with the following sequence: 2, 5ЈAAGUGGAUGCCUUUCGGGUCA-3Ј starting at the 30th codon (86th nucleotide in the open reading frame); 3, 5ЈAAGGAGAACAGUUCUUGCGGC-3Ј; and vps35, 5ЈAAGGUCCAGU-CAUUCCAAAUG-3Ј starting at the 24th codon (70th nucleotide in the open reading frame). HeLa cells were transfected twice at 72-h intervals with 200 nM of the siRNAs, using Oligofectamine (Invitrogen). After 144 h of siRNA treatment, the cells were transfected as described above for expression of Nef, CD4, and CD8. Human T cell lines and PBLs were electroporated once with 100 nM siRNA using the Amaxa system. The cells were rested for 24 -36 h before electroporating with an additional 100 nM siRNA and expression plasmids as indicated in the relevant figure legends.
RESULTS

HIV-1 Nef Delayed the Cell Surface Expression and Reduced the Cell Surface Density of de novo Synthesized CD4 -Initially,
we examined the kinetics of transport to the plasma membrane of de novo synthesized CD4 in the context of Nef expression. A2.01 (CD4-negative) T lymphocytes were co-infected with recombinant vaccinia viruses encoding WT CD4 (vCB-7) and NL4-3 HIV-1 Nef allele (vvNef) or a control virus (vSC8). Following 30 min of virus adsorption, cells were sampled at periodic intervals and examined by flow cytometry. Both sets of infected cells displayed similar levels of endogenous CD7 expression (not shown) that was used to monitor potential nonspecific effects of vaccinia virus infection on cellular receptor expression. The progress of vaccinia infection was monitored by flow cytometry of fixed and permeabilized cells stained with mAb against E3L protein, an early vaccinia virus gene product. Substantial E3L expression was observed in Ͼ60% of cells (not shown) in both sets of co-infections. vCB-7/vSC8-infected cells displayed significant cell surface CD4 expression by 2-3 h after infection, and by 6 h after infection, Ͼ60% of cells were positive for CD4 expression (Fig. 1, top row) . In contrast, vCB-7/vvNefinfected cultures lagged behind the vCB-7/vSC8 counterparts in the acquisition of CD4 surface staining and expressed significantly less CD4 at the cell surface. At 6 h after infection, only 20% or less of the vCB-7/vvNef-infected cells were positive for CD4 expression (Fig. 1A , bottom row). Nef expression was detected in vvNef cells (by immunoblotting) within 15-30 min after adsorption and continued unabated (not shown). When a recombinant vaccinia virus expressing tailless/truncated CD4 (tCD4) was used in place of WT CD4, Nef did not cause measurable difference in tCD4 expression (not shown). Thus, during simultaneous expression in T cells, Nef significantly delayed the cell surface expression and reduced the overall plasma membrane density of co-expressed CD4.
HIV-1 Nef Accelerated the Metabolic Turnover of Co-expressed CD4 in Recombinant Vaccinia Virus-infected T Cells and in Epithelial Cell
Transfectants-We then inquired whether the delayed cell surface appearance of CD4 in HIV-1 Nef (ϩ) cells reflected aberrant metabolic turnover of de novo synthesized receptor. A2.01 cells were infected with recombinant vaccinia viruses for WT CD4 (vCB-7) and vvNef or control vaccinia (vSC8). At the peak of early vaccinia gene expression (about 2 h after infection), the turnover rates of de novo synthesized CD4 and other recombinant proteins were evaluated in metabolic labeling experiments. As shown in Fig. 1B , there was a marked enhancement in the turnover rate of labeled CD4, with a t1 ⁄2 of about ϳ3 h. In contrast, CD4 in vSC8-infected cells remained stable throughout the chase period. The Nefinduced phenotype was specific for WT CD4. Nef had no effect on the turnover of tCD4 lacking the cytoplasmic tail.
Although HIV-1 Nef induced significant increase in the metabolic turnover of WT CD4, it had no effect on the unrelated CD46 expressed from a separate recombinant, vvCD46, that was included in the vSC8/vCB7 or vvNef/vCB7 co-infections (Fig. 1C, left) . When a HIV-1 gp160 recombinant, vPE16, was included in a similar triple infection, Nef expression actually induced a slight stimulation of gp160 labeling but no significant change in the turnover rate or processing of gp160 to (Fig. 1C, right) . When CD4 and gp160 are co-expressed, gp160 egress out of the endoplasmic reticulum might be hindered, resulting in the degradation of both CD4 and gp160 (40 -42) . The enhanced gp160 labeling probably reflected the reduced CD4 levels in the CD4/Nef co-infections, which might have spared the nascent gp160.
We confirmed the above results in HeLa and 293-T cells transiently expressing CD4 and HIV-1 Nef. HeLa and 293-T cells were co-transfected with CMV promoter-linked CD4, CD8, HIV-1 Nef, or Nef-Xho (null Nef) plasmids. Nef or Nef-Xho transfectants were adjusted to reflect equivalent CD8 (ϩ) cells and were subjected to pulse-chase labeling. Nef expression dramatically enhanced the metabolic turnover of nascent CD4 even during the first 30 min of metabolic chase, with a t1 ⁄2 of about 30 min in 293-T cells and ϳ1 h in HeLa cells (Fig. 2) . Thus, in both epithelial cells and T lymphocytes, HIV-1 Nef induced a rapid decay of nascent CD4, which might be occurring even during the receptor transport to the plasma membrane.
SIV Nef Was More Efficient than HIV-1 Nef in Accelerating CD4 Endocytosis in Both HeLa
Cells and Jurkat Lymphocytes-Next, we inquired whether enhanced CD4 endocytosis represented a significant mechanism for the loss of cell surface CD4 induced by HIV-1 and SIV Nef proteins. HeLa cells were transfected with CD4, CD8, and HIV-1 or SIV Nef or a null plasmid (NX). In parallel transfections, a CD4 mutant, LL/AA CD4, exchanging the dileucine codons at 413-414 of mature CD4 to dialanines, was substituted for WT CD4. HIV-1 Nef induced a 3-fold reduction of WT CD4 at the plasma membrane but was without effect on the LL/AA mutant (Fig. 3A, bottom) . We evaluated the endocytic rates for WT or LL/AA CD4 by determining the intracellular delivery of antibody bound to CD4 at the cell surface. The internalized fraction of fluorescent (PE) antibody bound to CD4 at the cell surface was calculated at different times after initial antibody binding. As expected, WT CD4 underwent brisk endocytosis in HeLa cells that lack the tyrosine kinase p56 lck which anchors CD4 to the plasma membrane in T cells (43) . In accord with other reports (12, 13) , LL/AA CD4 did not undergo constitutive endocytosis (Fig. 3A,  top plot) . HIV-1 Nef expression, which induced 3-fold or higher reduction in the CD4 levels at the plasma membrane (Fig. 3A,  lower panel) , increased the endocytic rate of the residual (3-fold reduced) CD4 at the cell surface only slightly (Fig. 3A, top  panel) . In contrast, SIV Nef induced a more significant endocytosis (2-fold higher initial rates) of residual cell surface CD4, resulting in internalization of Ͼ75% of the receptor from the cell surface before 60 min (Fig. 3B) . As shown for HIV-1 Nef, SIV Nef also failed to down-regulate or enhance endocytosis of LL/AA CD4 (Fig. 3B) .
Since HIV-1 Nef did not significantly accelerate CD4 endo- cytosis, we inquired whether HIV-1 Nef modulated the recycling kinetics of internalized CD4 in HeLa cells. PE-conjugated CD4 antibody bound to the cell surface was allowed to internalize over a 45-min period. After treatment at pH 2 to remove the residual antibody at the cell surface, cells were incubated to allow the antibody to recycle to the cell surface. Previous studies have shown that in HeLa cells and T lymphocytes lacking p56 lck, internalized CD4 is promptly returned to the cell surface via recycling endosomes, without encountering the low pH environment of late endosomes or lysosomes (12, 13) . HIV-1 Nef expression reduced significantly the initial rate of CD4 recycling during the first 10 min and induced a modest reduction in the total amount recycled over a 1-2-h period (Fig. 3C) . The loss of CD4 recycling in Nef (ϩ) cells might reflect reduced recycling rates or aberrant trafficking routing the internalized receptor to lysosomes, where antibody dissociation or CD4 degradation might occur.
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It was likely that any potential enhancement of CD4 endocytosis by Nef might be masked by the brisk constitutive recycling kinetics of CD4 in epithelial cells (13, 39) . Therefore, we examined CD4 endocytic kinetics in Jurkat T lymphocytes. As expected (44) , there was very little, if any, constitutive internalization of CD4 in these cells that have p56 lck anchoring CD4 to the plasma membrane (Fig. 3D) . Interestingly, both HIV-1 and SIV Nef accelerated CD4 endocytosis in Jurkat cells, although SIV Nef was significantly better in augmenting CD4 internalization over the first 10 -20 min. Table I summarizes the effects of HIV-1 or SIV Nef on the endocytic rates of CD4 in HeLa cells or Jurkat lymphocytes. Although HIV-1 Nef did not significantly enhance (ϳ20% increase) the intrinsic endocytic potential of CD4 in HeLa cells, SIV Nef was more potent, enhancing CD4 internalization 2-fold. With Jurkat lymphocytes, there was a significant difference in the magnitude of CD4 endocytosis induced by HIV-1 Nef (3.7-fold) versus SIV Nef (17-fold). Taken together, the above results highlighted mechanistic differences between HIV-1 and SIV Nef for CD4 down-regulation, with the endocytic enhancement being the preferred strategy used by SIV Nef.
HIV-1 Nef-induced Loss and Degradation of Presynthesized CD4 at the Plasma Membrane Was Blocked by Pretreatment
with Lysosomotropic Agents-Nef-induced CD4 loss at the plasma membrane might reflect intracellular sequestration or degradation of the receptor. Although HIV-1 and SIV Nef induced a 6-fold (Ϯ7%) or a 3.5-fold (Ϯ10%) loss of CD4 at the cell surface, the total cellular CD4 was reduced by 50% (Ϯ8%). Neither Nef protein had any demonstrable effect on the coexpressed CD8 (Fig. 4A) . To focus on the Nef effect on CD4 at the cell surface, we examined the effect of Nef in the absence of concurrent de novo CD4 synthesis. Toward this goal, we evaluated CD4 density on CD4 (ϩ) human T cells or a HeLa CD4 cell line expressing HIV-1 Nef from the recombinant vaccinia virus, vvNef. Since vaccinia virus shuts off host cell synthesis within minutes of virus entry, this approach allowed us to determine the metabolic turnover of presynthesized CD4 in the context of Nef expression. Human T lymphocytes expressing WT CD4 were infected with vvNef or vSC8 or left untreated. As illustrated in Fig. 4B , there was a 3.5-fold (Ϯ8%) loss of plasma membrane-associated CD4 in vvNef-infected cells. There was a proportionate decrease in total cellular CD4 (the immunoblot under the FACS histogram). Under the same conditions, Nef expression had no effect on the expression of endogenous CD2 or CD7 receptors in the same cell line (not shown). More pointedly, Nef expression did not alter the plasma membrane density of a CD4 mutant (tCD4), lacking the C-terminal tail and therefore being intrinsically incapable of being endocytosed (Fig. 4B, bottom) .
CD4 and other receptors that are internalized constitutively and/or after ligand binding are either recycled from the early endosomes or routed to the late endosomes and lysosomes, where they are degraded by acidic proteases. This proteolysis can be prevented by treatment of cells with weak bases or protease inhibitors. Therefore, we inquired whether weak bases such as NH 4 Cl or chloroquine would reverse the effect of Nef on presynthesized CD4 at the cell surface. As represented by the histograms in Fig. 4C , pretreatment with chloroquine completely reversed the 3-fold down-regulation of presynthesized endogenous CD4 in vvNef-infected T lymphocytes. Likewise, NH 4 Cl pretreatment efficiently blocked the net loss of CD4 at the cell surface of vvNef-infected HeLa CD4 cells (Fig.  4D) . Thus, aberrant trafficking of internalized CD4 to the lysosomes constituted an important mechanism of HIV-1 Nefinduced CD4 down-modulation. However, this mechanism could only be unraveled in the absence of ongoing CD4 synthesis.
Dominant-negative Inhibitors of Endocytosis Caused a Modest Inhibition of CD4 Down-regulation by HIV-1 Nef-We
next assessed the contribution of endocytosis to the HIV-1 Nefinduced loss of concurrently synthesized CD4. We evaluated the effect of Nef on CD4 in transient transfectants under conditions that inhibited endocytic trafficking. To block discrete steps in endocytic trafficking, we used GFP-or YFP-tagged dominant-negative inhibitor mutants of: dynamin, a known effector of vesicular traffic from the plasma membrane (45); Eps15, a critical regulator of clathrin-coated vesicle assembly (34, 46) ; and Rab5, required for clathrin-coated vesicle fusion with the early endosomes (47) .
HeLa cells, Jurkat lymphocytes, or CD4 (ϩ) PBLs were cotransfected GFP-or YFP-tagged fusion proteins listed above with HIV-1 Nef or a null Nef mutant, NX, and a CD4 plasmid for HeLa cells. CD4 expression was measured for GFP-gated transfectants by flow cytometry. First, we compared the effect of GFP versus various tagged fusion proteins on the steady- a Endocytosis rates were normally calculated over the first 5 min after warming to 37°C for HIV-1 Nef versus NX and over 10 min for SIV Nef versus NX. AA-CD4 refers to the 438LL/AA439 CD4 mutant. Endocytic rates were calculated over the initial 10 min for Jukat cells. In Jurkat cells, endocytosis was measured for the endogenous CD4 and in HeLa cells results are for the plasmid expressed CD4. Experimental details are given under "Experimental Procedures" and in the legend for Fig. 3 .
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state levels of endogenous CD4 in lymphocytes and plasmidexpressed CD4 in HeLa cells. In HeLa cells, the dominantnegative inhibitors induced a slight to modest increase in the cell surface CD4 MFV, varying from a low of 133% (Eps15 mutant) to 170% (Rab5 mutant). In Jurkat T cells and PBLs, the same mutants induced little or no difference in the steadystate levels of CD4 (data not shown). Nef down-regulated the cell surface density of the endogenous and plasmid-expressed CD4 5-fold (Ϯ6%) in lymphocytes and epithelial cells. In a pairwise comparison of CD4 MFVs in Nef(ϩ) versus Nef (Ϫ) HeLa cells, dominant-negative inhibitors of dynamin, Eps15, and Rab5 induced a modest reversal (44% (Ϯ6%), 30% (Ϯ8%), and 38% (Ϯ9%) for dynamin, Eps, and Rab5 mutants, respectively) in the magnitude of effect of Nef in both the epithelial cells and the lymphocytes (Fig. 5A) .
The above results were corroborated by immunofluorescence microscopy. Steady-state distribution of CD4 was examined in HeLa cell transfectants expressing CD4, Nef, and GFP or the GFP fusion proteins described above. In the absence of functional Nef expression, CD4 was at the cell surface (Fig. 5B) , whereas in the Nef-expressing cells, CD4 was predominantly distributed in perinuclear vesicles with very little at the plasma membrane (Fig. 5B , compare panels labeled NX & GFP and Nef & GFP). This pattern was unaltered in cells expressing GFP-tagged WT dynamin. K44A dynamin, Eps15, and Rab5 dominant-negative mutants slightly increased the presence of CD4 at the plasma membrane of HIV-1 Nef-expressing cells, although the majority of CD4 was still redistributed to intracellular vesicles (Fig. 5B) .
Dominant-negative Inhibitors of Endocytosis
Reversed SIV Nef-induced CD4 Down-regulation-We inquired whether enhanced endocytosis (Fig. 3) constituted the principal mechanism of SIV Nef-mediated CD4 loss at the cell surface. To this end, we compared the plasma membrane CD4 levels in SIV Nef(ϩ) versus SIV Nef (Ϫ) cells co-expressing selected dominant-negative inhibitors of endocytosis. In cells expressing GFP or GFP-tagged WT dynamin, SIV Nef induced nearly 7-fold (Ϯ 12%) reduction in the cell surface levels of CD4 (Fig.  6B) . The K44A dynamin mutant that blocks both clathrin-and non-clathrin-dependent internalization (45, 48, 49) induced 85% (Ϯ 15%) reversal of the effect of SIV Nef on CD4. The Eps15 mutant, a specific inhibitor of clathrin-coated vesicle assembly, was inefficient in this regard. Microscopic visualization of CD4 distribution confirmed these results. Although in GFP and WT dynamin GFP-expressing SIV Nef (ϩ) cells, CD4 was sequestered in intracellular vesicles, the receptor was pre- dominantly at the plasma membrane in cells expressing the K44A dynamin mutant (Fig. 6A) . CD4 internalization dynamics in these transfectants confirmed these findings. Although both Tfn and CD4 underwent brisk internalization in cells irrespective of their GFP expression levels (Fig. 6C, left panels) , endocytosis of both Tfn and CD4 was severely retarded in the K44A dynamin-expressing SIV Nef (ϩ) cells (Fig. 6C, right, compare the presence and absence of CD4 in the intracellular vesicles in the GFP cell versus the two K44A Dyn-GFP cells). These findings, combined with the results of Fig. 3 , strongly supported the conclusion that the effect of SIV Nef on CD4 was predominantly mediated by enhanced endocytosis. . At 30 h after transfection, cells were rinsed, fixed in 4% paraformaldehyde, and permeabilized in 0.1% Triton X-100 and then stained with CD4-APC before processing for microscopy. Individual channels corresponding to GFP and CD4 fluorescence extracted from the RGB images are shown.
SIV but Not HIV-1 Nef-induced CD4 Down-regulation Was Reversed by siRNA-induced Depletion of AP-2-Specialized
protein-coated vesicles mediate the sorting of transmembrane proteins during antero-and retrograde trafficking between the Golgi, trans-Golgi network, plasma membrane, endosomes, and lysosomes. There are four major heterotetrameric coat protein complexes, referred to as adaptors AP-1, AP-2, AP-3, and AP-4, which are composed respectively of two large (one FIG. 6 . Dominant-negative inhibition of endocytosis, notably by the K44A dynamin (Dyn) mutant, reversed the SIV Nef-mediated CD4 down-regulation. HeLa cells were transfected as in Fig. 5B except that SIV Nef was substituted for HIV-1 Nef. Identical DNA co-transfections were carried out simultaneously with 3 ϫ 10 6 cells seeded on 3 wells of a 6-well plate and 10 5 cells on 8-mm glass coverslips. A, steady-state distribution of CD4-expressing GFP or GFP-tagged WT dynamin, the K44A dynamin, or the Eps15⌬95/295 mutant. RGB channels of confocal images were separated to display cell morphology, CD4 staining, and GFP or GFP-tagged fusion proteins. B, pairwise comparison of relative CD4 MFVs (by flow cytometry) at the plasma membrane of SIV Nef (ϩ) versus Nef (Ϫ) (NX) cells (with the MFV in the NX cells of each pair arbitrarily set to 100) expressing GFP or GFP-tagged proteins. C, Tfn uptake and active CD4 endocytosis visualized simultaneously in cells expressing SIV Nef and GFP or GFP-tagged K44A dynamin mutant. CD4 endocytosis was measured by feeding transfectants APC-conjugated mAb and Texas-Red labeled Tfn as described under "Experimental Procedures." Cell surface-bound mAb and Tfn were stripped by acid wash before mounting. An RGB image of each field was separated into individual channels corresponding to GFP or GFP fusion protein, CD4, and Tfn.
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each of ␥/␣/␦/⑀ and ␤1-4), one medium (1-4), and one small (1-4) protein chain. Intracellular trafficking of membrane proteins is governed by specific interactions between signals in the cytoplasmic domain of membrane proteins with the adaptor protein components (1-3, 50) . Two tyrosine motifs at the Nterminal region of SIV Nef that mediate its binding to the AP-2 complex, presumably via the 2 subunit, have been shown to be critical for SIV Nef-induced CD4 down-regulation (17, 18) . Consistent with these observations, SIV Nef bound 2, and to a lesser extent, 1a and 4 adaptor subunits in the yeast 2-hybrid assay. Under the same conditions, HIV-1 Nef bound only the 1a subunit weakly (Fig. 7) . On the basis of this finding, we inquired whether the effect of SIV Nef on CD4 could be reversed by siRNA-induced knockdown of AP-2 complexes. Treatment of HeLa cells with siRNA against the 2 chain mRNA induced a marked depletion of AP-2 complexes as shown by immunofluorescence using antibody against ␣-adaptin. 2 siRNA had no effect on the distribution of AP-1 or AP-3 complexes (Fig. 8A) . Loss of AP-2 complexes induced by 2 siRNA treatment was correlated with impaired clathrinmediated endocytosis, demonstrated by the marked inhibition of transferrin uptake (Fig. 8B) . 2 siRNA treatment also increased the steady-state levels TfnR (CD71) 8-fold (Ϯ 20%), which reflected the strong inhibition of constitutive endocytosis of TfnR (Fig. 8B, bottom) . AP-2 depletion in HeLa cells resulted in a dramatic reversal (90% Ϯ 15%) of the effect of SIV Nef on CD4 expression (Fig. 8C, left panel) . AP-2 depletion did not rectify the residual (ϳ50% of WT) effect on CD4 of SIV Nef Y28A mutant, lacking the 2 binding potential. In contrast to SIV Nef, the effect of HIV-1 Nef on CD4 was only slightly (25% Ϯ 7%) reversed by 2 (Fig. 8C, right panel) knockdown. These results conclusively demonstrated that 2 depletion and the resulting decrease in the AP-2-dependent endocytosis impaired SIV Nef but not HIV-1 Nef-induced CD4 down-regulation.
DISCUSSION
Through multiple lines of evidence, we have shown that CD4 down-regulation by HIV-1 and SIV Nef proteins involves both internalization and intracellular retention mechanisms to different extents. SIV Nef predominantly enhanced endocytosis in an AP-2-dependent pathway. HIV-1 (NL4-3 strain) Nef, which binds to AP-1 and AP-3 hemicomplexes, but not AP-2 complex or subunits (15) , down-regulated CD4 by promoting intracellular retention of recycling and/or nascent CD4 and probable rerouting of the receptor to the lysosomes.
Many studies have underscored enhanced endocytosis as the prima facie mechanism of Nef-induced CD4 down-regulation and correlated this mechanism with the physical interaction of Nef with the subunits of AP-1 or AP-2 adaptor complexes (10, 11, 16 -18, 51-53) . We have shown that the few HIV-1 Nef alleles we tested interacted weakly, if at all, with the 2 subunit alone or in combination with the other adaptor subunits. However, we reported before that many different HIV-1 Nef alleles interacted with preformed ␥⅐1 and ␦⅐3 hemi-complexes of AP-1 and AP-3 adaptors via a (D/E)XXXL(L/I) sequence in the unstructured C-terminal loop of Nef (15) . As predicted from the lack of AP-2 binding, HIV-1 Nef did not significantly augment CD4 endocytic rate in HeLa cells. AP-1 and AP-3 regulate vesicular traffic of proteins between transGolgi network, endosomes, and plasma membrane, and as expected from such interactions, HIV-1 Nef reduced the recycling rate of internalized CD4 2-3-fold.
SIV Nef, which has both a canonical YXXØ sequence near the N terminus and a EEHYLMHPA sequence (where the -LM-dipeptide is highlighted in bold and the dileucine motif equivalent is underlined) near the C terminus, binds to the AP-2 adaptor (11, 17, 38) , via the 2 subunit (Ref. 18 and this study) and the ␥⅐1 AP-1 hemi-complex (15), respectively. Consistent with these properties, SIV Nef significantly enhanced the constitutive internalization of CD4 in HeLa cells. However, FIG. 7 . SIV Nef bound 2, and to a lesser extent 1a and 4 adaptor subunits of adaptor complexes, whereas HIV-1 Nef bound weakly and only to the 1a subunit. Two-hybrid analysis of interaction between full-length HIV-1 or SIV Nef with the different AP subunits (expressed from pGADT7 or pGAD424) as described elsewhere (15) is shown. Yeast cells were co-transformed with plasmids encoding the combination of constructs shown in the figure. Interactions were evidenced by growth on agar plates made with medium without histidine (ϪHis).
SIV Nef did not augment the internalization of the LL/AA CD4 mutant that lacked the AP-2 binding potential and was therefore not endocytosed constitutively (13) . Since SIV Nef binds AP-2 and probably CD4, these findings implied that SIV Nef reinforced weak CD4/AP-2 interactions.
It was of interest that both HIV-1 and SIV Nef enhanced CD4 internalization in Jurkat lymphocytes, wherein tethering of CD4 to the tyrosine kinase, p56 lck, inhibits constitutive receptor recycling (43, 44) . Both Nef proteins would be expected to dissociate p56 lck from CD4 in T cells (54) and thus allow constitutive CD4 internalization (13, 43) . The temporal lag in CD4 endocytosis in HIV-1 Nef cells probably reflected this process. The faster CD4 endocytic kinetics in the SIV Nef cells reflects the combination of enhanced AP-2 recruitment and CD4 dissociation from p56 lck.
Genetic perturbation of endocytic trafficking elucidated the relative importance of CD4 endocytosis in the receptor downmodulation by HIV-1 versus SIV Nef. Inhibition of clathrincoated vesicle assembly by the Eps15⌬95/295 mutant or endosomal traffic by the Rab5-S34N mutant induced a modest reversal of HIV-1 Nef-induced CD4 loss. However, the K44A dynamin mutant, an inhibitor of both clathrin-dependent and clathrin-independent endocytosis, was much better than the other inhibitors in partially rectifying the HIV-1 Nef effect. Microscopic analysis of CD4 distribution in cells expressing HIV-1 Nef and the various dominant-negative mutants corroborated the FACS analysis. In contrast, the effect of SIV Nef on CD4 was almost completely reversed by the K44A dynamin mutant in both the FACS and the microscopic assay. The Eps15⌬95/295 mutant was, however, much less efficient in this regard.
siRNA-driven AP-2 knockdown almost completely reversed the SIV Nef-induced CD4 down-regulation, thus corroborating the results observed with the dominant-negative inhibitors of endocytosis. Disruption of AP-2 vesicles by 2-specific siRNA treatment did not cause a comparable reversal of HIV-1 Nef effect on CD4. The SIV Nef Y28A mutant, lacking the AP-2 binding potential, had a residual effect on CD4 that was also resistant to 2 knockdown. An earlier report (17) suggested that SIV Nef employed both the dileucine and tyrosine motifs to promote CD4 internalization. However, our results suggest that tyrosine motif-based AP-2 sorting is the predominant mechanism for the WT SIV Nef, and the dileucine motif may be only operative when the tyrosine motif is mutated.
The ultimate test for the involvement of AP-1 in Nef-induced CD4 down-regulation in vivo would be to examine the effect of AP-1 depletion on this process. However, siRNA-induced knockdown of AP-1 vesicles was incomplete and did not consistently rectify the HIV-1 Nef-induced CD4 down-regulation. The fact that the inhibition of HIV-1 Nef effect was incomplete could be due to the small residual levels of AP-1 in the treated cells, usage of alternative isoforms of AP-1 subunits, the low threshold of AP-1 for the Nef effect, or the secondary contribution of AP-3 or other proteins to CD4 down-regulation.
There was substantial intracellular retention of CD4 in transport vesicles in HIV-1 Nef transfectants, which might represent internalized receptor stalled during recycling and/or nascent receptor en route to the plasma membrane. Using recombinant vaccinia viruses to simultaneously express CD4 and Nef in CD4-negative T cells, we showed that Nef markedly delayed the cell surface presentation of de novo CD4 and reduced its plasma membrane density 3-fold. It was unlikely that the delay (obvious within 1 h after infection) in the appearance of de novo synthesized CD4 at the plasma membrane of Nef (ϩ) cells resulted from enhanced endocytosis. More direct proof for an anterograde transport defect was obtained in pulse-chase labeling of recombinant vaccinia virus-infected cells. Nef induced a rapid turnover of nascent CD4 within 1-2 h of the metabolic chase. This defect was specific for CD4 with a cytoplasmic tail; truncated CD4 lacking the cytoplasmic domain and unrelated cellular and viral surface glycoproteins (such as CD46 and HIV-1 env gp160 and influenza virus HA (not shown) were unaffected by Nef. CD4 turnover rates were also markedly enhanced in epithelial cells with a t1 ⁄2 as brief as 30 min. Consistent with the previous reports (55, 56), Nef did not alter the rate or the magnitude of CD4 maturation in the Golgi when analyzed by acquisition of endoglycosidase H resistance (data not shown). Since endocytic degradation alone could not account for the short t1 ⁄2 (as long as the labeling time) of CD4 turnover in Nef-expressing cells, our findings implied that HIV-1 Nef was inducing intracellular retention of CD4 during the post-Golgi itinerary. An earlier report suggested that interaction of a diacidic motif of HIV-1 Nef with the ␤ subunit of COPI coatamers targeted the internalized CD4 for endosomal degradation (57) . However, a later report has shown that this diacidic motif was irrelevant for the effect of Nef on CD4 (58), and we have conclusively demonstrated the primacy of the dileucine motif for HIV-1 Nef-induced CD4 down-regulation (15) .
Notwithstanding the above results showing intracellular retention of concurrently synthesized CD4, Nef also induced aberrant recycling and intracellular degradation of plasma membrane-associated receptor. Using a vaccinia expression system, we demonstrated that Nef reduced the cell surface levels of presynthesized endogenous CD4 in both lymphocytes and epithelial cells. Since vaccinia virus shuts off host cell protein synthesis within a few minutes after virus entry, it is reasonable to conclude that the loss of cell surface CD4 resulted from aberrant endocytic recycling and lysosomal degradation of the receptor. Consistent with this scenario, treatment of cells with lysosomotropic agents such as NH 4 Cl or chloroquine almost completely inhibited the receptor loss induced by Nef. Although HIV-1 or SIV Nef moderately reduced the steady-state levels of CD4 during transient co-expression (Fig. 4A) , it was not possible to rectify the total CD4 loss for the following reasons. 1) Typically, steady-state CD4 was examined at 24 -48 h after in transfections, which was far longer than the limited duration (ϳ4 h) that the cells could be exposed to lysosomotropic agents without causing cytotoxicity. 2) It was not possible to discriminate in metabolic labeling experiments the effects of HIV-1 Nef on de novo synthesized CD4 in transit to or recycling from the plasma membrane since the Nef effects were obvious even at 20 min during the chase (Fig. 1B and 2 ). 3) Arresting protein synthesis with cycloheximide after brief labeling was not feasible since Nef turned over more rapidly with a t1 ⁄2 of ϳ1 h (not shown) than CD4 with a t1 ⁄2 of about 6 h in Nef(ϩ) and 12-18 h in Nef (Ϫ) cells. Nevertheless, it is worthwhile to highlight the different modus operandi of HIV-1 versus SIV Nef. SIV-1 Nef was much more potent than HIV-1 Nef in enhancing CD4 endocytosis in Jurkat T lymphocytes, and siRNA-mediated ablation of AP-2 vesicles was more efficient in reversing the SIV Nef effect. Therefore, the dominant effect of HIV-1 Nef on CD4 at the cell surface reflects aberrant recycling rather than enhanced endocytosis. Whether internalized by enhanced endocytosis or trapped intracellularly by retarded recycling, CD4 is degraded in the lysosomes.
In summary, our studies have shown that AP-2-mediated enhanced CD4 endocytosis is the predominant (if not the exclusive) mechanism used by SIV Nef, which has a canonical tyrosine motif near the N terminus that binds to the AP-2 2 subunit. HIV-1 (NL4-3) Nef, which lacks the tyrosine motif and the 2 binding potential, enhanced CD4 endocytosis only slightly. These conclusions must be tempered by the reality that our results for SIV Nef were obtained with human CD4 in human cells. Whether SIV Nef has evolved different strategies for interacting with non-human primate CD4 and/or adaptor complexes remains to be tested.
Physical interaction of HIV-1 Nef and CD4 has been demon-strated in insect cells overexpressing both proteins (19) , in yeast two-hybrid system (20) and in vitro binding assays using purified Nef protein and CD4 cytoplasmic domain peptides (21, 59) . In vitro binding of Nef to a CD4 C-tail peptide occurs via a hydrophobic patch on Nef including Trp-57, Leu-58, and Leu-110 residues and requires 2 leucines in the CD4 peptide (21) . However, stable complexes of HIV-1 Nef and LL/AA CD4 mutant have been demonstrated in mammalian cells, suggesting that the dileucine motif of CD4 may not be critical for Nef binding (60) . The dileucine motif in the C-tail of CD4 was shown to interact with the AP-1 complex (61, 62), albeit weakly and requiring phosphorylation at a proximal or a distal serine residue (13) . Both HIV-1 and SIV Nef have a dileucine motif and trap both the nascent CD4 en route to plasma membrane and the internalized CD4 during recycling, presumably through a tripartite recognition between the (D/E)XXXL(L/I) signal in Nef and the C-tail of CD4 with the two subunits of the AP-1 and AP-3 complexes, ␥1⅐1 and ␦⅐3, respectively (15) . Of the 10 different HIV-1 Nef alleles that we have tested for their effect on CD4, only NA-7 has both the canonical YXX⌽ tyrosine motif near the N terminus and an -LL-motif at position 164. Although we have not tested NA-7 Nef for its binding potential to the AP-2 2 subunit, siRNA-induced AP-2 knockdown failed to reverse the NA-7-induced CD4 down-modulation (data not shown). Although most SIV Nef alleles have both tyrosine and dileucine motifs, Nef encoded by the chimpanzee SIV-cpz (which is closely related to HIV-1) does not. Thus, it appears that HIV Nef proteins have evolved preferential usage of dileucine-based sorting mechanisms.
